Skip to main content
. 2023 Jul;44(7):799–806. doi: 10.3174/ajnr.A7907

Table 2:

Demographic and clinical features of 85 patients with laboratory-proved autoimmune encephalitis, stratified by antibody group

All (n = 85) Group 1 (n = 18) Group 2 (n = 67) P Value
Age (median) (IQR) 36 (24–62) 49.5 (29–64) 32 (22–61) .11
Male sex 25/85 (29%) 4/18 (22%) 21/67 (31%) .45
CSF leukocytosis 57/85 (67%) 11/18 (61%) 46/67 (69%) .69
CSF elevated protein 33/85 (39%) 11/18 (61%) 22/67 (33%) .06
Diagnosis of malignancy 15/85 (18%) 6/18 (33%) 9/67 (13%) .05
Diagnosis of teratoma/hamartoma 10/85 (12%) 2/18 (11%) 8/67 (12%) .95

Note:—IQR indicates interquartile range.